AnsellFRA:PD1 +3.01%74 FCF Margin % is 12.16% as of Dec. 2025, which is 36% above its 10-year median of 8.95. GuruFocus rates FRA:PD1 with a GF Score™ of 74/100 and a GF Value™ of €64.70. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Ansell ranks better than 74.36% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ansell's Free Cash Flow for the
six
months ended in Dec. 2025 was €107 Mil. Ansell's Revenue for the
six
months ended in Dec. 2025 was €877 Mil. Therefore, Ansell's FCF Margin % for the quarter that ended in Dec. 2025 was 12.16%.
The historical rank and industry rank for Ansell's FCF Margin % or its related term are showing as below:
FRA:PD1'
s FCF Margin % Range Over the Past 10 Years
Min: 4.45 Med: 8.95 Max: 14.01
Current: 10.33
During the past 13 years, the highest FCF Margin % of Ansell was 14.01%. The lowest was 4.45%. And the median was 8.95%.
FRA:PD1's FCF Margin % is ranked better than 74.36% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs FRA:PD1: 10.33
Ansell FCF Margin % Related Terms
Ansell FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ansell's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PD1 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Ansell's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ansell's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (FRA:PD1) has a FCF Margin % of 12.16% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ansell and its competitors. This is 36% above median its historical median of 8.95. Over the past decade, Ansell's FCF Margin % has ranged from 4.45 to 14.01. According to the industry distribution chart, Ansell ranks #209 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 25.6%.
Is Ansell's FCF Margin % too high?
Ansell's current FCF Margin % of 12.16% is 36% above median its 10-year median of 8.95. Over the past 10 years, this metric has ranged from a low of 4.45 to a high of 14.01. Based on the distribution chart, Ansell ranks #209 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ansell has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Ansell's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #209 out of 815 companies for FCF Margin %. This puts Ansell in the upper half of its industry. Historically, Ansell's own FCF Margin % has ranged from 4.45 to 14.01 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ansell and its competitors. Ansell's current FCF Margin % is 12.16%, which is 36% above median its own 10-year median of 8.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Ansell (FRA:PD1) has a current FCF Margin % of 12.16%. The stock's GF Value™ is €64.70, compared to a current price of €68.50 — trading 5.9% above its estimated fair value. The current FCF Margin % is 12.16%, which is 36% above median its 10-year median of 8.95. Ansell's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ansell (FRA:PD1), the current FCF Margin % is 12.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (FRA:PD1) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of €68.50 is trading 5.9% above its estimated GF Value™ of €64.70.
Key valuation signals for FRA:PD1:
FCF Margin %: 12.16% (36% above median its 10-year median of 8.95)
GF Value™: €64.70 vs. price of €68.50 (5.9% above fair value)
No single metric tells the full story. See the FRA:PD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
74GF Score
Get the complete analysis for FRA:PD1
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PD1 has been successfully added to your 
